New Boxed Warning for Deferasirox
This is a discussion on New Boxed Warning for Deferasirox within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The prescribing information for deferasirox has been updated to describe risks for kidney and liver failure and gastrointestinal hemorrhage and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
02-18-2010, 09:13 PM
|
|||
|
|||
New Boxed Warning for Deferasirox
The prescribing information for deferasirox has been updated to describe risks for kidney and liver failure and gastrointestinal hemorrhage and includes a new black box warning.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Early Communication about an Ongoing Safety Review of*Deferasirox (marketed as Exjade) | industry_news | FDA News | 0 | 09-25-2009 03:59 PM |
| FDA to Require Boxed Warning for Botulinum Toxin Products | industry_news | Other Clinical Pharmacy News | 0 | 04-30-2009 09:25 PM |
| Boxed Warning Highlights Risk for Infection With Raptiva | industry_news | Other Clinical Pharmacy News | 0 | 10-17-2008 09:04 PM |
| Warning Letter | industry_news | FDA News | 0 | 10-02-2008 05:12 PM |
| The prescribing information for Enbrel (etabercept) is revised to include a boxed warning about infections | industry_news | FDA News | 0 | 05-02-2008 12:28 PM |
© 2008 DrugManagementForum™ powered by |
 |